![]() |
InMed Pharmaceuticals, Inc. Suite #310-815 W. Hastings St. Vancouver, BC V6C 1B4 Canada |
November 10, 2020
VIA EDGAR
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549-7010
USA
Re: | InMed Pharmaceuticals Inc. |
Registration Statement on Form S-1
Filed June 19, 2020, as amended
File No. 333-239319
Reference is made to the letter dated November 5, 2020, pursuant to which InMed Pharmaceuticals Inc. (the Company) requested that the effective date of the above-referenced Registration Statement be accelerated to November 9, 2020 at 5:00 p.m. (Eastern), which date was subsequently revised to November 10, 2020 (the Acceleration Request).
The Company hereby withdraws the Acceleration Request, and respectfully requests that such Registration Statement not become effective at the date and time set forth in the Acceleration Request.
INMED PHARMACEUTICALS INC. | ||
By | /s/ Eric A. Adams | |
Name: Eric A. Adams Title: President & Chief Executive Officer |
))8SU5 MU!!_ U)10!E_\(YHG_0*L_\ ORM'_".:)_T"K/\ [\K6I15I!'2NE^&'_'IJ7_ %T3 M^1KN+J-9K.:-QE7C92/J*QJ5Y1J6Z&T*,90N>4>"M?FTS5XK221FL[E@C(3P MC'H1Z<]:[+XF3_9_AOKTF<9MBG_?1"_UKRJV8I=PL.JR*1^=>A_&6?R?A?J8 M_P">K0Q_G(O^%+$12FGW'0DW%H\K^#?A^W\1VWBC3[D?NY[-(@V/NDL2#^!4 M'\*I_#36;KP-\1VTG4<1Q7$ILKI2>%<'Y6'_ +]&KK?V>(OW6OS8_BA3]&- M9GQX\+BQUBU\1VR%8[S]U<%>TJCY6_%1_P".UE>\G%FEM+GT'7SC\;O$K:WX MKAT&R+R1:>=K*O.^=NP'? P/J37I6A_$.&3X1MXDGD62[LX#%,I/+3C@ _[Q M*G\:\O\ @]H$_BCQU+KM^?,BL7-Q([#[\[$[?URWX"IBK7;*D[Z(L_$OPE'X M4^'?A:U5 )TFD-RP_BE= 3^6W'T KTCX*W/F_#"R#'B":9#GM\Y/]:S/C]#O M\#V4O_//4$_5'KFO VJ2V/P$\320N5DA>9$(ZKO51G]33WB&TCGO'?C35OB% MXH71-',IT_SO)MK:,X\]NF]O4=2,\ ?C76:9^SW$U@K:IK ,-Q\RUO(05$@!Y5AZ],J<@@U]'>#?%$/ MBGPA::T0(F9"+A<\(Z\-^'&?H:\-^(_Q/TSQOH,%C;Z9 ]8EL/@AXO*,0T+LJ'T\Q%7^M$DVM1II/0YWQSXSU7XA>)UTW3C,U M@9O*L[1./-.<;V]2>O/0?C76Z7^SW-)9J^J:Z(+AADQ6\&]5]MQ(S^58WP%L M([GQO<73J";2T9DR.C,0N?RS^=?2-*4N71!%7U9\M^./A5JO@JQ?4!>Q7FFE MU1I%!C<$GC /^/+7_ /KK#_)JZ;XX?\DTN?\ KYA_]"KF?V>/ M^/+7_P#KK#_)J+MPU"UI'ME%%%9&@4444 %%%% !1110 4R7_5/_ +II],E_ MU3_[IH ^?_\ EK_P*NY^)7^MTK_KD_\ [+7#9_>_\"KN/B5_K=*_ZY/_ .RU MZ4_XD?F>?'X)?(N_##_CTU+_ *Z)_(UW -!UJ3^]=HOY)_] M>O1_&7A]/%'A/4-)8+YDT>86;^&0 G7M794YSNM!1 MC8\U^.<>_P"'+M_ ^ U>_?\*T\%_]"W8?]^Z\4^(GPVU7PIK;ZSHD4TFFM+YT M U;.<''. >A_.KNC?'W6[*V6'5-.MM09!@2JYB<_7@@G\!523EK$2:6C M/7O^%:>"_P#H6[#_ +]U4\3>#=+M?AWX@TS1-.AM/M%NTI2%<;W0;A^/R@5Y MCJ7[0.LW$1CTS1[2UD;@/*[3'\!\O]:]UT6[;4M T^\F4A[FVCD=2N,%E!(Q M^-0U);E*SV/G?X&:M!IWCIK6>0(+ZW:)"QP"X(8#\<&OI>OFWXC_ QU+PWJ M\FLZ%!++ICR>:OD E[5LYZ#G;GH1T[U8T/X]ZW86HM]4T^#4608$P M%FH:A= M.6A[311161H%%%% !1110 4444 %(<8YZ4M-D_U;?0T T@0:C8#+; M0[+A" ^L]2U.^L1!NDL3&'9U!!WKN&W\*\^\/:Q-/\.(-&@\, MZEJ,DL,D(W1(MN^689+LWW1GTJSH'AO4&U35;,:_?64]G;6<#-:["KR+ !N. MY23R.G%6T2>CQQ1Q B.-$SUVJ!FGUYW;>(UUCPYI1U#6=1M-382AXM*AWO-L M PR<5!IFKZOKHT+3Y-7NX/,N;Z">Y@B6*680D!"0RG:2.HP.:5 MF.YZ+]DMO^?>'_O@4LUO! U:%H^I^+=7U4KJ]WIEC82K;116>P,\FQ79W9E/'S@ #'2 ME8+G;45YD=8OM2NM5#Z_JMB;*9K2S2TT]Y5=D !DE(C8,6;/R@C KH/"VLZG MJFINNH*T+'2[6=[ 0>]>=/+?:[XBTB*;4;F"2 M/6-1ACG@"AT1$X494CIZBM36];U7P_>WEC;7KW4BV5K';O=!3B::=H_,;:!G M'''M3Y0N>@5R?BG1/"5IIUQK&K>'K&Y\LKO86J%V+,%'/'<^M)=6#:#IDUQJ M?B[5MLJ+$9&6,D2%A@QJL9.X\@#GK7&:WK$[Z5XBT@WNH7EHMM:W,+ZC;F*9 M"9U5EY5=R\ @X]:$@;/2=.\+>'])<2Z?HMA:R=GBMU5OSQFM>N"UN^N8?%%S M'JVLZEH^F[(A8SVR(('8CYO, GXTZRTE;/5]3U 2EFOFC8H1@)L7;^.:T:* .)L_ =SH\EO=:/K1M[ MQ(Y(97EMQ(DL;2M* 5R,%2YY!J]I/A Z?=V-W/J#7%Q;SW5P["(()'G.6XSP M!VKJ**=V*R,FST1;3Q)J>LB=F:_BAC,17A/+W <' XKJ:*+L5CDT M\*ZKI]S<3Z/X@-M]L(DNHYK594:; #2(,C:6P"1R,U9O_#NHR:E!JFFZT;6^ M%LMM<-);K)'<*"2"5R,$$MT/>NCHHNPL<9'X&N(+.V>#6675;>^EOENS;J5+ M2@AU*9^Z0?7/%69_!G]I)='5]1DN9KJT2W>6*,1%621G5UQG!!88_P!VNJHH MNPL<^$]=OX(8[[Q.9&M76:UDCLD5EE4\._)#<9!' .XU'<>![O53J4FLZS MY\]Y:+:J\%L(A$%?>K8R